Objective To assess the variation in baseline and seizure onset zone interictal high-frequency oscillation (HFO) rates and amplitudes across different anatomic brain regions in a large cohort of patients.
Patients with drug-resistant epilepsy frequently undergo invasive EEG monitoring to identify the origin of their seizures. Despite the associated invasiveness and infection risk, 1 15% of these patients do not undergo resective surgery, 2 and among resected cases, seizures recur in up to 40% of temporal 3, 4 and 54%-73% of extratemporal cases. 3, 5 Better biomarkers could improve the efficacy of epilepsy surgery by identifying previously overlooked pathologic tissue. 6 Highfrequency oscillations (HFOs) 7, 8 have been identified as biomarkers of seizure-generating tissue in the brain. [9] [10] [11] [12] [13] [14] [15] [16] HFOs have also been shown to have a role in normal cognitive processing and memory, 12, 17, 18 and differentiation between pathologic and normal physiologic oscillations remains challenging. 8, 19 Despite the well-known relationships between brain regions and cognitive tasks, and the role of HFOs in cognition, few studies have investigated spatial variation of HFOs. Studies of physiologic oscillations have focused on individual cognitive tasks in specific brain regions, but little data exist about the spatial distribution and characteristics of nonepileptogenic oscillations. Regional differences in cellular organization (e.g., archaecortex vs neocortex), function, and networks 20 suggest that significantly different baseline rates of HFOs may characterize different brain structures, and that accurately identifying pathologic brain tissue may require comparison to baseline HFO rates. The present study investigates the anatomic distribution of HFO counts and amplitudes 19 recorded in 70 patients, analyzed with a detection algorithm to provide an objective measure of HFO rates.
Methods
Standard protocol approvals, registrations, and patient consents The Mayo Clinic Institutional Review Board reviewed and approved all research data collection activities associated with this study, and written informed consent was obtained from all participants.
Data collection
Intracranial EEG (iEEG) recordings from a cohort of 70 patients (3,693 recorded channels in total) who underwent intracranial monitoring between October 2005 and February 2014 as part of their clinical presurgical evaluation with wide-bandwidth (5 kHz sampling) research EEG recordings and adequate perioperative imaging were analyzed in this work. Wide-bandwidth recordings were made in parallel with clinical iEEG recordings (512 Hz sampling rate) for evaluation for epilepsy surgery. 21 The patients underwent intracranial subdural and depth electrode implantation as part of their evaluation for epilepsy surgery. Data were acquired on a DC-capable Neuralynx (Bozeman, MT) electrophysiology system sampling at 32 kHz. The data were filtered using a Bartlett-Hanning window finite impulse response low-pass filter with cutoff at 1 kHz and decimated to a sampling frequency of 5 kHz. Raw data were stored in an open-source compressed electrophysiology file format (multiscale electrophysiology format) 21 that incorporates encryption of patient identifiers and cyclic redundancy checks to ensure data fidelity in compressed data blocks. Determination of clinical seizure onset zone (SOZ) and non-SOZ channels was made independently by the clinical team of board-certified epileptologists after reviewing the clinical iEEG data. Channels designated as uncertain SOZ or irritative zone were excluded from analysis.
Coregistration of preoperative MRI with postoperative CT and electrode localization As part of each patient's routine presurgical evaluation, a preoperative T1-weighted volumetric MRI was acquired, typically a sagittal magnetization-prepared rapid gradient echo (MPRAGE) (voxel dimensions 0.9375 × 0.9375 × 1.2 mm, repetition time 6.2 ms, echo time 2.4 ms, 8°flip angle, 3T field strength), although other coronal and axial MPRAGE and spoiled gradient recalled echo images with similar resolution were present as well. The preoperative MRI was preprocessed in FreeSurfer [22] [23] [24] to segment brain structures, extract the pial surface, extract the leptomeningeal surface (i.e., a smoothed pial surface), and map the patient's cortical surface to the FreeSurfer average cortical surface. As part of this process, each patient's cortical surface is mapped to the Desikan-Killiany brain atlas, 22 which assigns each neocortical vertex to 1 of 35 areas based on gyral morphology. Following electrode implantation, high-resolution X-ray CT images were acquired to confirm electrode placement. The postimplant CT volume was rigidly coregistered to the preoperative MRI using the FMRIB's linear image registration tool algorithm included in FSL 25, 26 via a 6 degrees of freedom affine transformation that maximized the mutual information between the 2 volumes. Resulting coregistered image volumes were visually inspected for accuracy. The coregistered CT volume was imported into BioImage Suite and electrode locations were manually labeled.
The cortical surface and apparent electrode positions in the postimplant CT sag or shift due to loss of CSF during surgery. 23, 24 To compensate for this issue, subdural grid and strip electrode coordinates are projected to the leptomeningeal surface using an inverse gnomonic projection method described by Yang et al. 27 The surface under each grid is Glossary D-K = Desikan-Killiany; HFO = high-frequency oscillation; iEEG = intracranial EEG; MPRAGE = magnetization-prepared rapid gradient echo; SOZ = seizure onset zone.
approximated as part of a larger sphere, and the algorithm iteratively adjusts the projection of the grid plane onto the sphere to minimize the difference between the projected and known electrode geometry. Subdural strip electrodes were assigned to the nearest leptomeningeal surface vertex and depth electrode coordinates were not corrected for brain shift. This brain shift correction was done in MATLAB (Mathworks Inc., Natick, MA) via iELVis, 28 which was also used for identifying and visualizing the anatomic location of electrodes.
SOZ electrodes were determined from the clinical iEEG report and verified independently by identifying the electrodes with the earliest iEEG seizure discharge. Seizure onset was determined as the earliest iEEG change in a clear electrographic seizure discharge.
Automated HFO detection was performed using a previously described detector 29 with high specificity and sensitivity HFO identification. The algorithm employs a cascade of adaptive frequency-dependent amplitude thresholds based on metric normalization, and artifacts and interictal spikes are excluded on the basis of the candidate detection's frequency content dominance. Algorithm measures were tuned with HFOs visually identified by expert reviewers. 30 The algorithm has excellent temporal precision and is efficient enough for real-time processing. In order to further assess the HFO detection algorithm's insensitivity to interictal spikes, we ran a commonly used spike detection algorithm 31 on our iEEG data, and evaluated the Pearson linear correlation coefficient between the detections.
Results
The 70-patient cohort consisted of 44 (63%) women and 26 (37%) men. Fifty-three (76%) were right-handed, 14 (20%) were left-handed, and 2 were undetermined or ambidextrous. Median age at onset of seizures was 13 years (range 0-48). Figure 1 shows the localizations of all 3,693 electrode SOZ (red) and non-SOZ (blue) contact positions with respect to the Desikan-Killiany (D-K) atlas (table e-1, links. lww.com/WNL/A170) parcellations in all 70 patients transformed into Montreal Neurological Institute atlas space. Electrode placement was determined entirely by the patient's clinical plan, and the distribution broadly covers the cerebral cortex. Note that in this figure depth electrode contacts lie below the cortical surface and are not visible. In this group of 70 patients, 50 (71%) went on to have resective epilepsy surgery, and of this group, 31 (62%) were seizurefree at last recorded follow-up (median 37.8 months, range 4.1-120.8 months). 
neocortical, HFO rates are significantly elevated in the SOZ in both categories (figure 2B). When parcellated into brain lobe and structure, the HFO rates were significantly elevated in SOZ compared with non-SOZ in parahippocampus, occipital lobe, and parietal lobe contacts, but did not show a significant difference in temporal neocortex or frontal lobe. Statistical significance was determined using the Wilcoxon rank sum test with p values adjusted for multiple comparisons using the Benjamini and Hochberg 32 false discovery rate correction.
Similarly, figure 3 shows the mean, median, and quartile HFO amplitudes in different brain regions, where SOZ contacts are shown in red and non-SOZ regions in blue. Figure 3A compares HFO amplitudes in aggregate over the entire brain and shows a significant difference between SOZ and non-SOZ electrodes. Figure 3B compares SOZ and non-SOZ HFO amplitudes in mesial temporal and neocortical regions, with statistically significant results in neocortical electrodes. When separated into individual lobes and structures, amplitude differences between SOZ and non-SOZ were statistically significant in the frontal lobe and parahippocampal region.
A one-way analysis of variance test on non-SOZ channels showed that the differences in the brain regions in figures 2C and 3C in HFO counts (F statistic = 24.8, p < 0.001) and HFO amplitudes (F statistic = 5.69, p < 0.001) are statistically significant. A 2-tailed paired t test comparing left and right atlas regions (excluding atlas subregions with no electrodes in one hemisphere) shows a significant difference in mean HFO rates (p < 0.01) and amplitudes (p < 0.05) between hemispheres. The mean HFO rates and amplitudes for individual substructures in the D-K atlas for non-SOZ region are shown in figures 4 and 5, respectively. Atlas regions with fewer than 4 contacts in this cohort were excluded and are shown in gray. The linear correlation between HFO and interictal spike detections was 0.108 (p < 0.001).
Discussion
The results presented in this study support the hypothesis that different brain regions and tissue types generate different baseline rates and amplitudes of HFOs. The non-SOZ HFO maps in figures 4 and 5 illustrate the hemispheric laterality effect on baseline HFO rates as well. In particular the precuneus, orbitofrontal, mesial temporal, and inferior occipital regions stand out as having large differences between homologous contralateral structures. The results also show a low positive correlation between detected HFOs and spikes, which would seem to support the HFO detector's ability to reject spikes. figure 4 is the elevation of baseline HFO rates in occipital cortex. One might assume this is related to the visual processing functions associated with occipital cortex, but the use of iEEG segments between 1 and 3 AM make it more likely the patients had eyes closed and were asleep during recording. There are reports describing visual cortex activation during REM sleep, 33 but without concurrent scalp EEG recording it is not possible to assess this. In our cohort, these regions were moderately sampled (29 contacts in right occipital cortex and 16 contacts on the left, 14 patients in total), so it is possible that the mean HFO activity in these regions might have been elevated by a few patients who were sleepless or in REM sleep. However, these data are also consistent with the possibility that the normal baseline rate of HFOs in occipital cortex is higher 
Also evident in
Of particular interest in this study is the variability of HFO rates and amplitudes, with large differences in SOZ and non-SOZ in some brain lobes and regions, but not in others. Previous reports describing HFOs as biomarkers of epileptogenic brain do not distinguish between brain regions, and employ a simple count of HFOs regardless of implanted structure to guide surgical resection of epileptogenic tissue. [34] [35] [36] The present study combined with others exploring spatial and temporal variations in HFO rates 37, 38 contribute to a more complicated model of HFO generation in the brain, and suggest that under some conditions HFO rates and amplitudes in pathologic and normal tissue may be indistinguishable. The present study also raises the possibility that an elevated rate of HFOs could be observed in channels over normal tissue solely due to spatial differences in baseline rates. These results suggest that HFO rate and amplitude thresholds could be normalized to a set of baseline rates and amplitudes for different brain regions to improve the accuracy of epileptogenic tissue identification for surgical resection.
These results also highlight the need for further research to clarify the differences in characteristics between HFOs generated by normal brain activity and HFOs generated by pathologic ictogenic tissue. In the analyses of non-SOZ HFOs, HFO rates and amplitudes measured outside clinically designated SOZ areas primarily describe oscillations arising from nonpathologic brain tissue. This is confirmed in cases where the entire group of SOZ electrodes was resected, and the patient subsequently achieved seizure freedom. However, for patients who did not undergo resection, or patients who had resective surgery but did not achieve seizure freedom, it is possible that some channels in the non-SOZ group may have recorded from pathologic tissue overlooked by conventional clinical analysis. While we acknowledge this is a weakness in the study, limiting the non-SOZ analysis to only patients with seizure-free outcomes postresection would have reduced the number of patients and electrodes to less than half the cohort, and would have precluded analysis of sparsely sampled regions. Furthermore, very few unidentified pathologic channels would be expected in each of the 39 patients with poor outcomes or without resective surgery, and the spatial distribution of these channels among brain regions in the cohort should be random, minimizing the effect on the analysis. The primary effect anticipated would be to slightly elevate non-SOZ HFO rates overall and artificially reduce the significance of SOZ to non-SOZ comparisons presented.
It should also be noted that the placement of subdural and depth electrodes was determined entirely by the patient's clinical indication, inevitably leading to an undersampling of nonpathologic brain tissue, as well as uneven sampling of anatomic regions. It is possible that in the 39 patients without resection or with poor outcomes that some brain regions reported as non-SOZ could in reality represent distant seizure foci not observed during the patient's intracranial monitoring. To assess these issues, we repeated the statistical tests shown in figures 2 and 3 for the 31 patients with seizure-free outcomes. Results of statistical testing for HFO count rates were identical (aggregate p < 0.001; mesial temporal p < 0.05, neocortical p < 0.05, parahippocampus p < 0.05, occipital p < 0.001, parietal p < 0.01) to those presented in figure 2 . For HFO amplitudes, differences between SOZ and non-SOZ channels in the 31 seizurefree patients were not significant for any comparison. These results suggest the HFO amplitude results are quite robust and not significantly influenced by potential inclusion of pathologic channels in non-SOZ statistics. The implications of the HFO amplitude result are less clear, as the loss of significance could be due to the reduction of sample size and statistical power, or could suggest that the significant results reported above are less robust and possibly influenced by uncontrolled confounds in our data.
This study demonstrates significant differences in rates and amplitudes of HFOs in SOZ and non-SOZ spanning the 38 anatomic regions defined by the D-K brain atlas, and between homologous regions in the left and right hemispheres. Significant SOZ vs non-SOZ differences in HFO counts were found in parahippocampal, occipital, and parietal regions, and differences in SOZ vs non-SOZ amplitudes were found in parahippocampal and frontal regions. However, significant differences between SOZ and non-SOZ counts and amplitudes were not observed in some lobes and structures (e.g., temporal neocortex). Further, differences in baseline, non-SOZ HFO rates and amplitudes were demonstrated among brain lobes. This analysis highlights the importance of considering measured HFO counts and amplitudes in the context of their anatomic locations in order to accurately differentiate between normal and pathologic, seizure-generating brain tissue.
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